BMC Neurol
- MOTL RW, Bombardier CH, Duffecy J, Hibner B, et al
Study protocol: exercise training for treating major depressive disorder in
multiple sclerosis.
BMC Neurol. 2024;24:131.
- HOLZ A, Obi N, Ahrens W, Berger K, et al
Childhood and adolescence factors and multiple sclerosis: results from the German
National Cohort (NAKO).
BMC Neurol. 2024;24:123.
Brain
- HUANG J, Tengvall K, Bomfim Lima I, Hedstrom AK, et al
Genetics of immune response to Epstein-Barr virus: prospects for multiple
sclerosis pathogenesis.
Brain. 2024 Apr 17:awae110. doi: 10.1093.
Clin Exp Immunol
- MARTIN-GUTIERREZ L, Waddington KE, Maggio A, Coelewij L, et al
Dysregulated Lipid Metabolism Networks Modulate T-cell Function in People with
Relapsing Remitting Multiple Sclerosis.
Clin Exp Immunol. 2024 Apr 16:uxae032. doi: 10.1093.
J Neuroimmunol
- MUNZ C
Altered EBV specific immune control in multiple sclerosis.
J Neuroimmunol. 2024;390:578343.
J Neurol
- SPIEZIA AL, Scalia G, Petracca M, Caliendo D, et al
Effect of siponimod on lymphocyte subsets in active secondary progressive
multiple sclerosis and clinical implications.
J Neurol. 2024 Apr 17. doi: 10.1007/s00415-024-12362.
- HIRT J, Dembowska K, Woelfle T, Axfors C, et al
Clinical trial evidence of quality-of-life effects of disease-modifying therapies
for multiple sclerosis: a systematic analysis.
J Neurol. 2024 Apr 16. doi: 10.1007/s00415-024-12366.
- SINGER BA, Feng J, Chiong-Rivero H
Early use of high-efficacy therapies in multiple sclerosis in the United States:
benefits, barriers, and strategies for encouraging adoption.
J Neurol. 2024 Apr 14. doi: 10.1007/s00415-024-12305.
J Neurol Neurosurg Psychiatry
- ABDEL-MANNAN O, Champsas D, Tur C, Lee V, et al
Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein
antibody-associated disease (MOGAD) and its relevance to disease course.
J Neurol Neurosurg Psychiatry. 2024;95:426-433.
Mult Scler
- OZTURK B, Taskiran E, Demir S, Tuncer MA, et al
Prevalence and incidence of multiple sclerosis in Turkey: A nationwide
epidemiologic study.
Mult Scler. 2024 Apr 14:13524585241245318. doi: 10.1177/13524585241245318.
- TOOSY AT, Barkhof F
Multiple sclerosis can be diagnosed solely with dissemination in space: Yes.
Mult Scler. 2024 Apr 14:13524585241245313. doi: 10.1177/13524585241245313.
- MCGINLEY MP, Cohen JA
Multiple sclerosis can be diagnosed solely with dissemination in space:
Commentary.
Mult Scler. 2024 Apr 14:13524585241245319. doi: 10.1177/13524585241245319.
- HEMOND CC, Solomon AJ
Multiple sclerosis can be diagnosed solely with dissemination in space: No.
Mult Scler. 2024 Apr 14:13524585241245297. doi: 10.1177/13524585241245297.
- CHITNIS T, Banwell B, Kappos L, Arnold DL, et al
Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label
extension of TERIKIDS.
Mult Scler. 2024 Apr 15:13524585241242050. doi: 10.1177/13524585241242050.
- OKUDA DT, Lebrun-Frenay C
Radiologically isolated syndrome in the spectrum of multiple sclerosis.
Mult Scler. 2024 Apr 15:13524585241245306. doi: 10.1177/13524585241245306.
Nat Med
- ZAMECNIK CR, Sowa GM, Abdelhak A, Dandekar R, et al
An autoantibody signature predictive for multiple sclerosis.
Nat Med. 2024 Apr 19. doi: 10.1038/s41591-024-02938.
PLoS One
- YAGHOOBPOOR S, Fathi M, Vakili K, Sayehmiri F, et al
Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: A
systematic review and meta-analysis.
PLoS One. 2024;19:e0297091.
- LOMER NB, Asalemi KA, Saberi A, Sarlak K, et al
Predictors of multiple sclerosis progression: A systematic review of conventional
magnetic resonance imaging studies.
PLoS One. 2024;19:e0300415.
Rev Neurol
- RODRIGUEZ-MENENDEZ S, Martinez-Piedrola RM, Menendez-Gonzalez M, Perez-de-Heredia-Torres M, et al
Influence of manipulative skills on quality of life and activities of daily
living in multiple sclerosis.
Rev Neurol. 2024;78:213-218.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016